OptiBiotix Health (LON:OPTI) Shares Down 2% – Here’s Why

OptiBiotix Health Plc (LON:OPTI)’s share price dropped 2% during trading on Monday . The company traded as low as GBX 5.50 and last traded at GBX 5.50. 2,352 shares changed hands during trading, a decline of 99% from the average daily volume of 388,060 shares. The stock had previously closed at GBX 5.61.

OptiBiotix Health Price Performance

The business’s 50 day moving average is GBX 6.04 and its 200-day moving average is GBX 6.01. The company has a market cap of £5.68 million, a PE ratio of -1.43 and a beta of 1.85.

OptiBiotix Health (LON:OPTI) last announced its quarterly earnings data on Thursday, May 28th. The company reported GBX (3.84) EPS for the quarter. OptiBiotix Health had a negative net margin of 333.62% and a negative return on equity of 52.92%. The firm had revenue of GBX 117 million during the quarter.

Insider Buying and Selling

In other OptiBiotix Health news, insider David Blain purchased 158,965 shares of the business’s stock in a transaction on Thursday, May 28th. The shares were bought at an average cost of GBX 6 per share, for a total transaction of £9,537.90. 26.79% of the stock is owned by company insiders.

About OptiBiotix Health

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.

OptiBiotix is also developing its own range of consumer supplements and health products.